A study of effectiveness of injection Depot medroxyprogester
Depot medroxyprogesterone (DMPA) injection 150 mg intramuscular was used in postpartum women for contraception in this study, once every 3 months.

The study aims to accept and comply with DMPA, observe side effects related to the usage of DMPA, and establish its effectiveness as a postpartum contraception method.

This is a prospective study carried out at the Obstetrics and Gynaecology department over a period of 9 months and follow-up was done. Only patients of full-term normal delivery and Lower segment cesarean section (LSCS) were included.

- Out of 50 cases selected maximum patients, 48% were in the age group of 26 to 30, 38% were from lower socioeconomic class.

- Amenorrhoea and irregular spotting were found in 68% and 42% respectively. There was no case of failure of this contraceptive method in this study.

DMPA is an effective and safe method of contraception in the lactating period. Proper counseling will increase acceptance of DMPA.

Source: http://dx.doi.org/10.18203/2320-1770.ijrcog20212967